DrugDashboards

Desipramine Hydrochloride

Desipramine Hydrochloride · DESIPRAMINE HYDROCHLORIDE 10 mg/1 · Tablet, Film Coated · Oral · Alembic Pharmaceuticals Inc.

NDC 62332-0315-31 · 100 TABLET, FILM COATED in 1 BOTTLE · ANDA · View full market →

The short version

Just 3 companies supply this market — thin enough that a single exit would be felt immediately. The price is up 13% over the past year, to $0.1551 per unit. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want. Historically, drugs in this position went on to a new shortage within 90 days about 0.3% of the time — roughly 2× the typical drug (0.1%).

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$0.1551per EAinvoice-surveyed acquisition cost · Aug 19, 2026
  • Medicaid generic ceiling (FUL)$0.1551per TABweighted avg manufacturer price $0.0554 · Aug 1, 2026100% of what pharmacies pay — higher than 10% of drugs with this benchmark

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.2$0.4$0.6Oct 2021Sep 2026$0.1551
43 price points · per EA · dashed = manufacturer avg (WAMP)Source: CMS NADAC

Estimated fill cost

#30 count
$4.65
#90 count
$13.96

Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.

Medicaid spend (2025)

$1,299
86 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

10Low risk

Some pressure is visible, but not much — here’s everything the score found to count.

  • 3 active manufacturers+10

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.3%chance of a new FDA shortage posting for desipramine hydrochloride (oral solid) in the next 90 days

6 Class I/II recall(s) in 12 months · OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is 2× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA209785
TE code
AB
Approval date
Jul 7, 2021
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Desipramine Hydrochloride (Tablet, Film Coated)

LabelerStrengthFirst seenLast seen
Actavis Pharma, Inc.DESIPRAMINE HYDROCHLORIDE 150 mg/1Jul 15, 2026Sep 2, 2026
Actavis Pharma, Inc.DESIPRAMINE HYDROCHLORIDE 75 mg/1Jul 15, 2026Sep 2, 2026
Actavis Pharma, Inc.DESIPRAMINE HYDROCHLORIDE 25 mg/1Jul 15, 2026Sep 2, 2026
Actavis Pharma, Inc.DESIPRAMINE HYDROCHLORIDE 100 mg/1Jul 15, 2026Sep 2, 2026
Actavis Pharma, Inc.DESIPRAMINE HYDROCHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Actavis Pharma, Inc.DESIPRAMINE HYDROCHLORIDE 50 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals Inc.DESIPRAMINE HYDROCHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals Inc.DESIPRAMINE HYDROCHLORIDE 100 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals Inc.DESIPRAMINE HYDROCHLORIDE 150 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals Inc.DESIPRAMINE HYDROCHLORIDE 25 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals Inc.DESIPRAMINE HYDROCHLORIDE 50 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals Inc.DESIPRAMINE HYDROCHLORIDE 75 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals LimitedDESIPRAMINE HYDROCHLORIDE 100 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals LimitedDESIPRAMINE HYDROCHLORIDE 75 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals LimitedDESIPRAMINE HYDROCHLORIDE 50 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals LimitedDESIPRAMINE HYDROCHLORIDE 150 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals LimitedDESIPRAMINE HYDROCHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals LimitedDESIPRAMINE HYDROCHLORIDE 25 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Desipramine Hydrochloride — NDC 62332-0315-31," retrieved September 3, 2026, https://drugdashboards.com/drug/62332031531.

Free to cite with attribution — see how the data is put together.